{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:41:38Z","timestamp":1790628098913,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":3050,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1038\/sj.ki.5002338","type":"journal-article","created":{"date-parts":[[2007,5,16]],"date-time":"2007-05-16T12:08:26Z","timestamp":1179317306000},"page":"260-264","source":"Crossref","is-referenced-by-count":256,"title":["Gadolinium and nephrogenic systemic fibrosis"],"prefix":"10.1016","volume":"72","author":[{"given":"T.","family":"Grobner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.C.","family":"Prischl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/sj.ki.5002338_bb0010","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1001\/archderm.139.7.928","article-title":"What nephrogenic fibrosing dermopathy might be","volume":"139","author":"Leboit","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1038\/sj.ki.5002338_bb0015","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/archderm.139.7.903","article-title":"Nephrogenic fibrosing dermopathy with systemic involvement","volume":"139","author":"Ting","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1038\/sj.ki.5002338_bb0020","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1053\/j.ajkd.2005.06.024","article-title":"Nephrogenic fibrosing dermopathy\/nephrogenic systemic fibrosis: Report of a new case with literature review","volume":"46","author":"Daram","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5002338_bb0025","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/00000372-200110000-00001","article-title":"Nephrogenic fibrosing dermopathy","volume":"23","author":"Cowper","year":"2001","journal-title":"Am J Dermatopathol"},{"key":"10.1038\/sj.ki.5002338_bb0030","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0002-9343(03)00085-8","article-title":"Nephrogenic fibrosing dermopathy: a novel cutaneous fibrosing disorder in patients with renal failure","volume":"114","author":"Swartz","year":"2003","journal-title":"Am J Med"},{"key":"10.1038\/sj.ki.5002338_bb0035","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0140-6736(00)02694-5","article-title":"Scleromyxedema-like cutaneous disease in renal-dialysis patients","volume":"356","author":"Cowper","year":"2000","journal-title":"Lancet"},{"key":"10.1038\/sj.ki.5002338_bb0040","doi-asserted-by":"crossref","first-page":"234","DOI":"10.7326\/0003-4819-145-3-200608010-00021","article-title":"Nephrogenic fibrosing dermopathy and high dose erythropoetin therapy","volume":"145","author":"Swaminathan","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1038\/sj.ki.5002338_bb0045","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1001\/archderm.140.11.1401","article-title":"Nephrogenic fibrosing dermopathy: are ACE inhibitors the missing link?","volume":"140","author":"Fazeli","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1038\/sj.ki.5002338_bb0050","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1067\/mjd.2003.78","article-title":"Nephrogenic fibrosing dermopathy (scleromyxedema-like illness of renal disease)","volume":"48","author":"Mackay-Wiggan","year":"2003","journal-title":"Am Acad Dermatol"},{"key":"10.1038\/sj.ki.5002338_bb0055","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/00002281-200311000-00017","article-title":"Nephrogenic fibrosing dermopathy: the first six years","volume":"15","author":"Cowper","year":"2003","journal-title":"Curr Opin Rheumatol"},{"key":"10.1038\/sj.ki.5002338_bb0060","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/ndt\/gfk062","article-title":"Gadolinium \u2013 a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?","volume":"21","author":"Grobner","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5002338_bb0065","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1681\/ASN.2006060601","article-title":"Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging","volume":"17","author":"Marckmann","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5002338_bb0070","year":"2006"},{"key":"10.1038\/sj.ki.5002338_bb0075","series-title":"Biochemistry of the Lanthanides","author":"Evans","year":"1990"},{"key":"10.1038\/sj.ki.5002338_bb0080","doi-asserted-by":"crossref","first-page":"619","DOI":"10.2214\/ajr.142.3.619","article-title":"Characteristics of gadolinium\u2013DTPA complex: a potential NMR contrast agent","volume":"142","author":"Weinmann","year":"1984","journal-title":"Am J Roentgenol"},{"key":"10.1038\/sj.ki.5002338_bb0085","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0730-725X(87)90023-3","article-title":"Biodistribution of GdCl3 and Gd\u2013DTPA and their influence on proton magnetic relaxation in rat tissues","volume":"5","author":"Barnhardt","year":"1987","journal-title":"Magn Reson Imaging"},{"key":"10.1038\/sj.ki.5002338_bb0090","first-page":"231","article-title":"The reticuloendothelial-blocking effect of rare earth metals in rats","volume":"13","author":"Lazar","year":"1973","journal-title":"J Reticuloendothel Soc"},{"key":"10.1038\/sj.ki.5002338_bb0095","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0009-2797(99)00109-X","article-title":"The events relating to lanthanide ions enhanced permeability of human erythrocyte membrane: binding, conformational change, phase transition and ion transport","volume":"121","author":"Cheng","year":"1999","journal-title":"Chem-Biol Interact"},{"key":"10.1038\/sj.ki.5002338_bb0100","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1148\/radiol.2273012007","article-title":"Gadodiamide administration causes spurious hypocalcemia","volume":"227","author":"Prince","year":"2003","journal-title":"Radiology"},{"key":"10.1038\/sj.ki.5002338_bb0105","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1021\/ic00107a017","article-title":"Novel contrast agents for magnetic resonance imaging. Synthesis and characterisation of the ligand BOPTA and its Ln(III) complexes","volume":"34","author":"Uggeri","year":"1995","journal-title":"Inorg Chem"},{"key":"10.1038\/sj.ki.5002338_bb0110","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S1076-6332(98)80191-8","article-title":"Pharmacokinetics of gadodiamide injection in patients with severe renal insufficiency and patients undergoing hemodialysis or continuous ambulatory peritoneal dialysis","volume":"5","author":"Joffe","year":"1998","journal-title":"Acad Radiol"},{"key":"10.1038\/sj.ki.5002338_bb0115","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/028418501127346756","article-title":"Safety of gadolinium contrast agent in hemodialysis patients","volume":"42","author":"Okada","year":"2001","journal-title":"Acta Radiol"},{"key":"10.1038\/sj.ki.5002338_bb0120","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1097\/00004728-199301001-00004","article-title":"Stability of gadolinium complexes in vitro and in vivo","volume":"17","author":"Mann","year":"1993","journal-title":"J Comput Assist Tomogr"},{"key":"10.1038\/sj.ki.5002338_bb0125","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1093\/ndt\/gfg064","article-title":"Iron-mobilizing properties of the gadolinium\u2013DTPA complex: clinical and experimental observations","volume":"18","author":"Vorobiov","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5002338_bb0130","first-page":"437","article-title":"Free gadolinium and gadodiamide, a gadolinium chelate used in magnetic resonance imaging: evaluation of their in vitro effects on human neutrophil viability","volume":"18","author":"Behra-Miellet","year":"1996","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"10.1038\/sj.ki.5002338_bb0135","series-title":"Contrast Media. Safety Issues and ESUR Guidelines","author":"Thomsen","year":"2006"},{"key":"10.1038\/sj.ki.5002338_bb0140","first-page":"1","article-title":"Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned","volume":"188","author":"Broome","year":"2007","journal-title":"Am J Radiol"},{"key":"10.1038\/sj.ki.5002338_bb0145","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/ndt\/gfg506","article-title":"Nephrogenic fibrosing dermopathy: a novel, disabling disorder in patients with renal failure","volume":"49","author":"Evenepoel","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1038\/sj.ki.5002338_bb0150","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jaad.2006.10.048","article-title":"Gadolinium deposition in nephrogenic fibrosing dermopathy","volume":"56","author":"Boyd","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1038\/sj.ki.5002338_bb0155","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jaad.2006.10.047","article-title":"Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis","volume":"56","author":"High","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/sj.ki.5002338_bb0160","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.biocel.2003.10.005","article-title":"Circulating fibrocytes: collagen secreting cells of the peripheral blood","volume":"36","author":"Quan","year":"2004","journal-title":"Int J Biochem Cell Biol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815526483?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815526483?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T04:57:44Z","timestamp":1546837064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815526483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S0085253815526483"],"URL":"https:\/\/doi.org\/10.1038\/sj.ki.5002338","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}